Skip to main content

Advertisement

Table 3 Weight and height z-scores according to month since start of treatment and average CS dose in period

From: The effects of long-term medication on growth in children and adolescents with ADHD: an observational study of a large cohort of real-life patients

Average dose in previous period Period (months from start)
0–11 12–47 48–71 72+
Weight z-score change since baseline
 0–0.4 mg/kg
  Number of persons 332 52 31 21
  Average (SD) −0.24 (0.32) −0.26 (0.70) −0.15 (1.04) −0.32 (0.90)
 0.5–1.4 mg/kg
  Number of persons   271 165 83
  Average (SD)   −0.51 (0.64) −0.48 (0.89) −0.25 (1.00)
 1.5+ mg/kg
  Number of persons   6 4 1
  Average (SD)   −0.61 (0.21) −0.93 (0.13) −1.47 (0.00)
Height z-score change since baseline
 0–0.4 mg/kg     
  Number of persons 331 51 30 21
  Average (SD) −0.08 (0.20) −0.15 (0.41) −0.16 (0.71) −0.44 (0.60)
 0.5–1.4 mg/kg
  Number of persons   271 165 83
  Average (SD)   −0.28 (0.44) −0.47 (0.64) −0.51 (0.75)
 1.5+ mg/kg
  Number of persons   6 47 1
  Average (SD)   −0.43 (0.25) −0.89 (0.45) −0.12 (0.00)